Coverage dated August 10, 2023

Insurers won't cover new Alzheimer's treatment for some customers

Headline from Madison

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.

Madison's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

12 articles, oldest first.

Madison
Insurers won't cover new Alzheimer's treatment for some customers (opens Madison)
Published Aug 10, 2023
Madison's feed description
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.
CBS News
Some Pennsylvania insurers won't cover new Alzheimer's treatment for some customers (opens CBS News)
Published Aug 10, 2023
CBS News's feed description
Some private insurers in Pennsylvania are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.
WMUR
Private health insurers won't cover new Alzheimer's treatment for some customers (opens WMUR)
Published Aug 10, 2023
WMUR's feed description
Their decision stands in contrast to Medicare, which will wind up covering most patients who take the drug.
CBS News
Highmark among insurers not covering new Alzheimer's treatment for some customers (opens CBS News)
Published Aug 10, 2023
CBS News's feed description
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer's patients.
PBS NewsHour
Insurers view new Alzheimer’s drug as experimental, won't cover treatment for some customers (opens PBS NewsHour)
Published Aug 10, 2023
PBS NewsHour's feed description
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.